Pure Global

"Dark" pathology diagnosis of glandular tumor markers with primary antibodies (unsterilized) - Taiwan Registration 3377fdc8a35c5d3a62ee2228ad1f54d3

Access comprehensive regulatory information for "Dark" pathology diagnosis of glandular tumor markers with primary antibodies (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 3377fdc8a35c5d3a62ee2228ad1f54d3 and manufactured by Agilent Technologies, Inc.. The authorized representative in Taiwan is SCN TRADING COMPANY LIMITED.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Agilent Technologies Denmark ApS., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
1 Competitors
1 Recent Registrations
3377fdc8a35c5d3a62ee2228ad1f54d3
Registration Details
Taiwan FDA Registration: 3377fdc8a35c5d3a62ee2228ad1f54d3
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Dark" pathology diagnosis of glandular tumor markers with primary antibodies (unsterilized)
TW: "้”ๅ…‹" ็—…็†่จบๆ–ท่…บ่…ซ็˜คๆจ™่จ˜็”จไธ€็ดšๆŠ—้ซ” (ๆœชๆป…่Œ)
Risk Class 1

Registration Details

3377fdc8a35c5d3a62ee2228ad1f54d3

DHA04401116408

Company Information

United States

Product Details

Limit the classification and grading management of medical equipment "immunopathological histochemical reagents and sets (B.1860) the first level identification range.

B Hematology, pathology, and genetics

B.1860 Immunopathological histochemistry reagents and kits

import

Dates and Status

Dec 21, 2011

Dec 21, 2026

Companies Making Similar Products
Top companies providing products similar to ""Dark" pathology diagnosis of glandular tumor markers with primary antibodies (unsterilized)"